Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Maxim updates Maxamine clinical trial program

July 8, 1999

Astra (AstraZeneca) presents new agents for GI inflammatory disorders

July 5, 1999

Howard Hughes researchers uncover mechanism of interferon resistance in HCV

July 5, 1999

Naturally occurring anti-H. pylori substances discovered by Takeda

July 2, 1999

Relief in sight for female patients with IBS: Glaxo Wellcome files NDA for alosetron

July 1, 1999

Shiseido describes new gastric antisecretory agents for ulcers

June 30, 1999

Enzon and Schering-Plough revise agreement for PEG-Intron

June 30, 1999

Antiinflammatory mechanism(s) of orazipone undergoes study at Orion

June 29, 1999

Immunex renews gene license with Digital Gene Technologies

June 25, 1999

Amarillo Biosciences reaches IFN-alpha development agreement in China

June 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.